Frank Dekker partner in funded Horizon Europe project
The team of Prof. Frank Dekker of the Groningen Research Institute of Pharmacy (GRIP) participates in a Horizon Europe project that was recently funded. The project is called 'In Armor' and concerns the pre-clinical development of small molecule inhibitors of histone lysine deacetylases (HDAC) for the induction of antimicrobial peptides. The project will be performed by a consortium of 16 participants from 11 different European countries with a total budget of EUR 6 million. The Dekker team is funded with EUR 390,000 to work on the synthesis and characterization of a focussed collection of HDAC inhibitors that will be taken into pre-clinical development.
Last modified: | 15 June 2023 4.23 p.m. |
More news
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
-
22 April 2025
Microplastics and their effects on the human body
Professor of Respiratory Immunology Barbro Melgert has discovered how microplastics affect the lungs and can explain how to reduce our exposure.